Nxera Pharma (OTCMKTS:SOLTF – Get Free Report) is expected to be issuing its resultson Friday, October 30th. Analysts expect Nxera Pharma to post earnings of $0.0032 per share and revenue of $51.94 million for the quarter.
Nxera Pharma Stock Performance
Shares of OTCMKTS SOLTF opened at $8.50 on Wednesday. Nxera Pharma has a fifty-two week low of $4.90 and a fifty-two week high of $8.50. The business has a 50 day moving average price of $7.54 and a two-hundred day moving average price of $6.30.
About Nxera Pharma
Nxera Pharma Co, Ltd., formerly known as Sosei Group Corporation and Sosei Heptares, is a biopharmaceutical company focused on discovering and developing medicines that target G protein-coupled receptors (GPCRs). These receptors are involved in a wide range of biological processes and represent an important class of targets for treatments in areas including neuroscience, immunology, inflammation, metabolic disease and other therapeutic fields.
The company combines structure-based drug design, computational chemistry and its proprietary StaR technology to identify and optimize drug candidates.
Read More
- Five stocks we like better than Nxera Pharma
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
